secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2021-08-25T23:59:59+00:00
Accession:  0001104659-21-109371
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm CFO Preetam Shah resigns, Controller Alla Patlis named Interim CFO
-----------------------------------------------------------------------------

- CFO Preetam Shah resigned effective Aug 31, 2021; no disagreement with the Company or Board.
- Controller Alla Patlis appointed Interim CFO effective upon Shah's departure if no permanent CFO named.
- Patlis has served as Controller since Dec 2012 and previously as Interim CFO in 2015 and 2016-2017.
- No change in Patlis's current compensation for the additional Interim CFO role.
- Company plans to interview candidates for a permanent CFO successor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/0001104659-21-109371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/tm2125922d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-109371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer